AI vs. pathologists: Which diagnoses cancer better?
Part of Brain & nervous system, Cancer, Kidney & urinary, Lungs & breathing, Women’s health & pregnancy clinical trials.
This study tests a new AI system called COSMO against pathologists to see which is better at diagnosing cancer from digital slides. If you are an experienced pathologist, you will review slides independently, and your results will be compared with the AI's.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be a board-certified pathologist with a specialty in neuropathology, lung, or urologic pathology (or general anatomical pathology).
- You need at least 3 years of experience diagnosing tissue slides in a clinical setting.
- You must currently work in a job that involves reading diagnostic pathology slides.
- You agree to review up to 300 digital slide images on a secure platform within a set time frame.
- You cannot have been part of creating or testing the COSMO AI system before.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether an AI tool helps pathologists make more accurate diagnoses when looking at tissue samples. It may lead to better and faster diagnoses for patients in the future.
This trial tests how well artificial intelligence (AI) helps pathologists make diagnoses from digital tissue images. It may lead to faster and more accurate results for patients like you.
This trial uses artificial intelligence to analyze your pathology slides, radiology images, and medical records together. It aims to see how well AI can help with diagnosis or treatment planning, and you may qualify if your medical data is available and of good quality.
This trial compares treatment recommendations from large language models (AI) against those from experienced tumor boards for five common cancer types. The goal is to see if AI can help doctors make better decisions.
This trial tests an artificial intelligence (AI) method that reads whole slide pathology images to classify how aggressive your lung adenocarcinoma is. It may help doctors diagnose the lung cancer grading system more accurately using existing lab slides after surgery.
This study tests an artificial intelligence (AI) system that uses your health information and medical images to better judge cancer risk and support diagnosis and treatment decisions. It may help doctors make more consistent assessments by combining clinical records, imaging, and other lab-style data.
Hear when a new Brain Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.